期刊文献+

How do resident stem cells repair the damaged myocardium? 被引量:2

How do resident stem cells repair the damaged myocardium?
下载PDF
导出
摘要 It has been a decade since the monumental discovery of resident stem cells in the mammalian heart, and the following studies witnessed the continuous turnover of cardiomyocytes and vascular cells, maintaining the homeostasis of the organ. Recently, the autologous administration of c-kit-positive cardiac stem cells in patients with ischemic heart failure has led to an incredible outcome; the left ventricular ejection fraction of the celltreated group improved from 30% at the baseline to 38% after one year and to 42% after two years of cell injection. The potential underlying mechanisms, before and after cell infusion, are explored and discussed in this article. Some of them are related to the intrinsic property of the resident stem cells, such as direct differentiation, paracrine action, and immunomodulatory function, whereas others involve environmental factors, leading to cellular reverse remodeling and to the natural selection of "juvenile" cells. It has now been demonstrated that cardiac stem cells for therapeutic purposes can be prepared from tiny biopsied specimens of the failing heart as well as from frozen tissues, which may remarkably expand the repertoire of the strategy against various cardiovascular disorders, including non-ischemic cardiomyopathy and congenital heart diseases. Further translational investigations are needed to explore these possibilities. It has been a decade since the monumental discoveryof resident stem cells in the mammalian heart, and thefollowing studies witnessed the continuous turnoverof cardiomyocytes and vascular cells, maintaining thehomeostasis of the organ. Recently, the autologousadministration of c-kit-positive cardiac stem cells inpatients with ischemic heart failure has led to an incredibleoutcome; the left ventricular ejection fraction of the celltreatedgroup improved from 30% at the baseline to 38%after one year and to 42% after two years of cell injection.The potential underlying mechanisms, before and aftercell infusion, are explored and discussed in this article.Some of them are related to the intrinsic property of theresident stem cells, such as direct differentiation, paracrineaction, and immunomodulatory function, whereas othersinvolve environmental factors, leading to cellular reverseremodeling and to the natural selection of "juvenile" cells.It has now been demonstrated that cardiac stem cells fortherapeutic purposes can be prepared from tiny biopsiedspecimens of the failing heart as well as from frozentissues, which may remarkably expand the repertoireof the strategy against various cardiovascular disorders,including non-ischemic cardiomyopathy and congenitalheart diseases. Further translational investigations areneeded to explore these possibilities.
出处 《World Journal of Stem Cells》 SCIE CAS 2015年第1期182-185,共4页 世界干细胞杂志(英文版)(电子版)
基金 The Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research(C),No.25461118
关键词 Regeneration Heart failure Cell therapy C-KIT CARDIAC stem cells Cellular REVERSE REMODELING Mircrine Regeneration Heart failure Cell therapy C-kit Cardiac stem cells Cellular reverse remodeling Mircrine
  • 相关文献

参考文献24

  • 1[K] Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F,Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, LeriA, Kajstura J, Nadal-Ginard B, Anversa P. Adult cardiac stemcells are multipotent and support myocardial regeneration.Cell 2003; 114: 763-776 [PMID: 14505575 DOI: 10.1016/S0092-8674(03)00687-1]. 被引量:1
  • 2[K] Kajstura J, Gurusamy N, Ogórek B, Goichberg P, Clavo-Rondon C, Hosoda T, D’Amario D, Bardelli S, Beltrami AP,Cesselli D, Bussani R, del Monte F, Quaini F, Rota M, BeltramiCA, Buchholz BA, Leri A, Anversa P. Myocyte turnover inthe aging human heart. Circ Res 2010; 107: 1374-1386 [PMID:21088285 DOI: 10.1161/CIRCRESAHA.110.231498]. 被引量:1
  • 3[K] Bearzi C, Rota M, Hosoda T, Tillmanns J, Nascimbene A, DeAngelis A, Yasuzawa-Amano S, Trofimova I, Siggins RW,Lecapitaine N, Cascapera S, Beltrami AP, D’Alessandro DA,Zias E, Quaini F, Urbanek K, Michler RE, Bolli R, KajsturaJ, Leri A, Anversa P. Human cardiac stem cells. Proc NatlAcad Sci USA 2007; 104: 14068-14073 [PMID: 17709737 DOI:10.1073/pnas.0706760104]. 被引量:1
  • 4[K] De Angelis A, Piegari E, Cappetta D, Marino L, FilippelliA, Berrino L, Ferreira-Martins J, Zheng H, Hosoda T, RotaM, Urbanek K, Kajstura J, Leri A, Rossi F, Anversa P.Anthracycline cardiomyopathy is mediated by depletion ofthe cardiac stem cell pool and is rescued by restoration ofprogenitor cell function. Circulation 2010; 121: 276-292 [PMID:20038740 DOI: 10.1161/CIRCULATIONAHA.109.895771]. 被引量:1
  • 5[K] Hosoda T. C-kit-positive cardiac stem cells and myocardialregeneration. Am J Cardiovasc Dis 2012; 2: 58-67 [PMID:22254215]. 被引量:1
  • 6[K] Bolli R, Chugh AR, D’Amario D, Loughran JH, StoddardMF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T,Sanada F, Elmore JB, Goichberg P, Cappetta D, Solankhi NK,Fahsah I, Rokosh DG, Slaughter MS, Kajstura J, Anversa P.Cardiac stem cells in patients with ischaemic cardiomyopathy(SCIPIO): initial results of a randomised phase 1 trial.Lancet 2011; 378: 1847-1857 [PMID: 22088800 DOI: 10.1016/S0140-6736(11)61590-0]. 被引量:1
  • 7[K] Bolli R, Chugh A, D’Amario D, Loughran JH, StoddardMF, Ikram S, Wagner SG, Beache GM, Leri A, Hosoda T,Goichberg P, Fiorini C, Solankhi N, Fahsah I, Elmore JB,Rokosh DG, Slaughter MS, Kajstura J, Anversa P. Effect ofcardiac stem cells in patients with ischemic cardiomyopathy:interim results of the SCIPIO trial up to 2 years aftertherapy [abstract]. Circulation 2012; 126: 2784 [DOI: 10.1161/CIR.0b013e318278c90d]. 被引量:1
  • 8[K] Chugh AR, Beache GM, Loughran JH, Mewton N, ElmoreJB, Kajstura J, Pappas P, Tatooles A, Stoddard MF, LimaJA, Slaughter MS, Anversa P, Bolli R. Administration ofcardiac stem cells in patients with ischemic cardiomyopathy:the SCIPIO trial: surgical aspects and interim analysis ofmyocardial function and viability by magnetic resonance.Circulation 2012; 126: S54-S64 [PMID: 22965994 DOI: 10.1161/CIRCULATIONAHA.112.092627]. 被引量:1
  • 9[K] Smith RR, Barile L, Cho HC, Leppo MK, Hare JM, Messina E,Giacomello A, Abraham MR, Marbán E. Regenerative potentialof cardiosphere-derived cells expanded from percutaneousendomyocardial biopsy specimens. Circulation 2007; 115: 896-908[PMID: 17283259 DOI: 10.1161/CIRCULATIONAHA.106.655209]. 被引量:1
  • 10[K] Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE,Berman D, Czer LS, Marbán L, Mendizabal A, Johnston PV,Russell SD, Schuleri KH, Lardo AC, Gerstenblith G, Marbán E.Intracoronary cardiosphere-derived cells for heart regenerationafter myocardial infarction (CADUCEUS): a prospective,randomised phase 1 trial. Lancet 2012; 379: 895-904 [PMID:22336189 DOI: 10.1016/S0140-6736(12)60195-0]. 被引量:1

同被引文献5

引证文献2

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部